1. Home
  2. THQ vs FTH Comparison

THQ vs FTH Comparison

Compare THQ & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Healthcare Opportunities Fund Shares of Beneficial Interest

THQ

abrdn Healthcare Opportunities Fund Shares of Beneficial Interest

HOLD

Current Price

$19.49

Market Cap

779.0M

Sector

Finance

ML Signal

HOLD

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

N/A

Current Price

$28.74

Market Cap

860.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
THQ
FTH
Founded
2014
N/A
Country
United States
United States
Employees
N/A
29
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
779.0M
860.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
THQ
FTH
Price
$19.49
$28.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
196.3K
314.5K
Earning Date
01-01-0001
N/A
Dividend Yield
7.53%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.49
$17.50
52 Week High
$20.39
$37.90

Technical Indicators

Market Signals
Indicator
THQ
FTH
Relative Strength Index (RSI) 65.22 57.42
Support Level $18.90 $22.69
Resistance Level $20.14 $31.61
Average True Range (ATR) 0.22 2.82
MACD 0.05 -0.37
Stochastic Oscillator 98.02 71.16

Price Performance

Historical Comparison
THQ
FTH

About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest

abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Share on Social Networks: